HHS weighs rescinding Moderna bird flu vaccine contract
- The U.S. Department of Health and Human Services is considering withdrawing a $590 million contract for a bird flu vaccine awarded to Moderna Inc., as reported by Bloomberg.
- Health officials are reviewing a $590 million contract granted to Moderna Inc. For a bird flu vaccine, as reported by Bloomberg.
- This contract was awarded during the Biden administration's final days and helped raise Moderna's stock by 13% shortly after the announcement.
- The reconsideration occurs amidst a significant bird flu outbreak and declining sales of Moderna's COVID-19 vaccine.
Insights by Ground AI
Does this summary seem wrong?
10 Articles
10 Articles
All
Left
2
Center
7
Right
1
Coverage Details
Total News Sources10
Leaning Left2Leaning Right1Center7Last UpdatedBias Distribution70% Center
Bias Distribution
- 70% of the sources are Center
70% Center
L 20%
C 70%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage